Thereby, our present CSF data do not robustly support findings from the recent study in plasma which reported significantly elevated levels of d18:1 GlcSph in participants with and without PD carrying a heterozygous GBA1 N370S variant compared to PD and healthy participants without GBA1 variant9. This evidence concerns the gene GBA1 and Parkinson disease.